ImmunityBio (IBRX) EBIT Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 55.96% |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | 14.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.48% |
| Dec 31, 2025 | 8.67% |
| Sep 30, 2025 | 15.07% |
| Jun 30, 2025 | 3.62% |
| Mar 31, 2025 | 12.44% |
| Dec 31, 2024 | 4.34% |
| Sep 30, 2024 | -0.60% |
| Jun 30, 2024 | -4.96% |
| Mar 31, 2024 | -3.34% |
| Dec 31, 2023 | -40.35% |
| Sep 30, 2023 | -6.75% |
| Jun 30, 2023 | -18.70% |
| Mar 31, 2023 | -44.87% |
| Dec 31, 2022 | -74.02% |
| Sep 30, 2022 | -78.13% |
| Jun 30, 2022 | -66.35% |
| Mar 31, 2022 | -73.63% |
| Dec 31, 2021 | -64.78% |
| Sep 30, 2021 | -48.43% |
| Jun 30, 2021 | -44.83% |
| Mar 31, 2021 | -45.02% |
| Dec 31, 2020 | -6.74% |
| Sep 30, 2020 | -39.17% |
| Jun 30, 2020 | -28.82% |
| Mar 31, 2020 | -12.96% |
| Dec 31, 2019 | 13.79% |
| Sep 30, 2019 | 21.15% |
| Jun 30, 2019 | 20.91% |
| Mar 31, 2019 | 16.61% |
| Dec 31, 2018 | 16.03% |
| Sep 30, 2018 | 19.64% |
| Jun 30, 2018 | 39.92% |
| Mar 31, 2018 | 4.13% |
| Dec 31, 2017 | -112.89% |
| Sep 30, 2017 | -198.50% |
| Jun 30, 2017 | -170.91% |
| Mar 31, 2017 | -213.56% |